Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria

Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in Austria.

Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong

Abacus Medicine Pharma Services (AMPS) and Luye Pharma Group are proud to announce the signing of an exclusive distribution contract to make Lurbinectedin available to small cell lung cancer patients in Hong Kong via the Named Patient Program (NPP).

Webinar: Mitigating CTS costs post-COVID

What do Clinical Trials, San Antonio (Texas), COVID-19, Madrid, Aposave and Burlingame (California) have in common?